Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10

12:26 EDT 20 Jul 2017 | PR Newswire

LOVELAND, Colo., July 20, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity 37th Annual Growth Conference at 9 a.m. ET on Thursday, August 10, 2017.

The conference will be held August 9-10, 2017 at the InterContinental Boston Hotel in Boston, Mass.

A live webcast of the group presentation will be available at  This webcast will be archived for 90 days following the live presentation. Management will be available during the day on August 10 for one-on-one meetings. To schedule a one-on-one meeting, please contact Hayden IR at

About Heska

Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit

View original content:

SOURCE Heska Corporation


More From BioPortfolio on "Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10"

Quick Search

Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...